研究
2015以前 研究業績・論文発表
論文
Komoike Y, Inokuchi M, Itoh T, Kitamura K, Kutomi G, Sakai T, Jinno H, Wada N, Ohsumi S, Mukai H; Japanese Breast Cancer Society.
Japan Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer.
Breast Cancer. 2015 Jan;22(1):37-48.
Tsurutani J, Kuroi K, Iwasa T, Miyazaki M, Nishina S, Makimura C, Tanizaki J, Okamoto K, Yamashita T, Aruga T, Shigekawa T, Komoike Y, Saeki T, Nakagawa K.
Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.
Cancer Sci. 2015 Jun;106(6):734-9.
Sakiyama T, Tsurutani J, Iwasa T, Kawakami H, Nonagase Y, Yoshida T, Tanaka K, Fujisaka Y, Kurata T, Komoike Y, Nishio K, Nakagawa K.
A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer.
Br J Cancer. 2015 Mar 3;112(5):819-24.
Okumura Y, Nishimura R, Nakatsukasa K, Yoshida A, Masuda N, Tanabe M, Shien T, Tanaka S, Arima N, Komoike Y, Taguchi T, Iwase T, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.
Eur J Surg Oncol. 2015 Apr;41(4):548-52.
Isono S, Fujishima M, Azumi T, Hashimoto Y, Komoike Y, Yukawa M, Watatani M.
O6-methylguanine-DNA methyltransferase as a prognostic and predictive marker for basal-like breast cancer treated with cyclophosphamide-based chemotherapy.
Oncol Lett. 2014 Jun;7(6):1778-1784.
Ishitobi M, Okumura Y, Nishimura R, Nakatsukasa K, Tanabe M, Yoshida A, Masuda N, Shien T, Tanaka S, Komoike Y, Arima N, Taguchi T, Inaji H; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR.
Breast Cancer. 2014 Nov;21(6):754-60.
Takashima T, Nakayama T, Yoshidome K, Kawajiri H, Kamigaki S, Tsurutani J, Arai T, Ito T, Komoike Y, Doi T, Masuda N, Miyauchi K, Miyoshi Y, Sakamoto J, Morita S, Taguchi T.
Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.
Anticancer Res. 2014 Jul;34(7):3583-8.
Ishitobi M, Suzuki O, Komoike Y, Ohsumi S, Nakahara S, Yagi T, Yoshinami T, Tomita Y, Inaji H.
Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients.
Breast Cancer. 2014 Sep;21(5):550-6.
Ishitobi M, Shibuya K, Komoike Y, Koyama H, Inaji H.
Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients.
Patient Prefer Adherence. 2013 Nov 22;7:1201-6.
Mizoo T, Taira N, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Komoike Y, Miyoshi S.
Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women.
BMC Cancer. 2013 Dec 1;13:565.
Matsuoka H, Tsurutani J, Tanizaki J, Iwasa T, Komoike Y, Koyama A, Nakagawa K.
Regression of brain metastases from breast cancer with eribulin: a case report.
BMC Res Notes. 2013 Dec 18;6:541.
Okita Y, Narita Y, Suzuki T, Arita H, Yonemori K, Kinoshita T, Fujiwara Y, Tsuda H, Komoike Y, Nakagawa H, Tamaki Y, Tomita Y, Shibui S, Maruno M.
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.
Mol Clin Oncol. 2013 Nov;1(6):995-1001